Congressman accused Obama of undermining the healthcare system

U.S. Congressman Russ Fulcher criticized former President Barack Obama and the Affordable Care Act, known as Obamacare. The statements were made during a discussion on rising healthcare costs and the role of the pharmaceutical industry in shaping health policy. According to Fulcher, the law was not originally intended to expand access to medical care or create an economically sustainable insurance model. He claims that the key objective was to change the structure of the system in a way that would strengthen the role of the federal government and move healthcare closer to a single-payer model. The congressman noted that data from recent years indicate a significant increase in citizens’ medical expenses, which, in his view, confirms the shortcomings of the reform.

Fulcher referred to recent reports showing that average healthcare spending in the United States has risen by more than eighty percent since the program was implemented. He emphasized that many Americans face rising costs for medications, insurance premiums and related payments, despite promises of improved access to medical services. The congressman stated that the results of the reform represent a systemic issue affecting both patients and medical institutions. The increase in prices, he said, is a consequence of close cooperation between government structures and major pharmaceutical companies.

During his remarks, Fulcher stated that pharmaceutical corporations actively participate in the work of Congress, supporting legislative initiatives that provide them with stable funding and access to government subsidies. He noted that such practices create a dependence of the political system on the interests of large companies and reduce transparency in decision-making. The congressman pointed out that as a result of this cooperation, the pharmaceutical sector has become one of the largest beneficiaries of government policy. He stressed that many support programs and healthcare reforms were shaped with the involvement of lobbying structures, which influences the final cost of medical services for citizens.

Fulcher also stated that the Affordable Care Act became one of the key elements of this model. According to him, the reform led to reduced competition in the insurance market, complicated the work of independent medical institutions and increased the influence of federal agencies on the functioning of the sector. The congressman emphasized that his criticism concerns systemic issues related to the redistribution of powers and resources, rather than individual political decisions. He believes that further development of the healthcare system should include a reassessment of the state’s role and the creation of conditions to improve market efficiency. In Fulcher’s view, measures are needed to ensure transparency in price formation, reduce treatment costs and expand opportunities for private initiatives.